6-43780906-T-C

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The ENST00000480614.1(VEGFA):​n.6589T>C variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.974 in 1,612,486 control chromosomes in the GnomAD database, including 765,635 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.98 ( 73054 hom., cov: 30)
Exomes 𝑓: 0.97 ( 692581 hom. )

Consequence

VEGFA
ENST00000480614.1 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -1.01

Publications

6 publications found
Variant links:
Genes affected
VEGFA (HGNC:12680): (vascular endothelial growth factor A) This gene is a member of the PDGF/VEGF growth factor family. It encodes a heparin-binding protein, which exists as a disulfide-linked homodimer. This growth factor induces proliferation and migration of vascular endothelial cells, and is essential for both physiological and pathological angiogenesis. Disruption of this gene in mice resulted in abnormal embryonic blood vessel formation. This gene is upregulated in many known tumors and its expression is correlated with tumor stage and progression. Elevated levels of this protein are found in patients with POEMS syndrome, also known as Crow-Fukase syndrome. Allelic variants of this gene have been associated with microvascular complications of diabetes 1 (MVCD1) and atherosclerosis. Alternatively spliced transcript variants encoding different isoforms have been described. There is also evidence for alternative translation initiation from upstream non-AUG (CUG) codons resulting in additional isoforms. A recent study showed that a C-terminally extended isoform is produced by use of an alternative in-frame translation termination codon via a stop codon readthrough mechanism, and that this isoform is antiangiogenic. Expression of some isoforms derived from the AUG start codon is regulated by a small upstream open reading frame, which is located within an internal ribosome entry site. The levels of VEGF are increased during infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), thus promoting inflammation by facilitating recruitment of inflammatory cells, and by increasing the level of angiopoietin II (Ang II), one of two products of the SARS-CoV-2 binding target, angiotensin-converting enzyme 2 (ACE2). In turn, Ang II facilitates the elevation of VEGF, thus forming a vicious cycle in the release of inflammatory cytokines. [provided by RefSeq, Jun 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 6-43780906-T-C is Benign according to our data. Variant chr6-43780906-T-C is described in ClinVar as Benign. ClinVar VariationId is 1278094.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.986 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VEGFANM_003376.6 linkc.1034+103T>C intron_variant Intron 6 of 7 ENST00000672860.3 NP_003367.4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VEGFAENST00000672860.3 linkc.1034+103T>C intron_variant Intron 6 of 7 NM_003376.6 ENSP00000500082.3

Frequencies

GnomAD3 genomes
AF:
0.980
AC:
149012
AN:
152116
Hom.:
72995
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.994
Gnomad AMI
AF:
0.980
Gnomad AMR
AF:
0.978
Gnomad ASJ
AF:
0.951
Gnomad EAS
AF:
1.00
Gnomad SAS
AF:
0.990
Gnomad FIN
AF:
0.975
Gnomad MID
AF:
0.972
Gnomad NFE
AF:
0.971
Gnomad OTH
AF:
0.970
GnomAD2 exomes
AF:
0.978
AC:
245080
AN:
250640
AF XY:
0.977
show subpopulations
Gnomad AFR exome
AF:
0.995
Gnomad AMR exome
AF:
0.986
Gnomad ASJ exome
AF:
0.948
Gnomad EAS exome
AF:
1.00
Gnomad FIN exome
AF:
0.974
Gnomad NFE exome
AF:
0.970
Gnomad OTH exome
AF:
0.973
GnomAD4 exome
AF:
0.974
AC:
1422085
AN:
1460252
Hom.:
692581
Cov.:
45
AF XY:
0.974
AC XY:
707405
AN XY:
726446
show subpopulations
African (AFR)
AF:
0.995
AC:
33253
AN:
33424
American (AMR)
AF:
0.985
AC:
44049
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.948
AC:
24776
AN:
26132
East Asian (EAS)
AF:
1.00
AC:
39687
AN:
39700
South Asian (SAS)
AF:
0.989
AC:
85271
AN:
86190
European-Finnish (FIN)
AF:
0.973
AC:
51785
AN:
53206
Middle Eastern (MID)
AF:
0.967
AC:
4575
AN:
4730
European-Non Finnish (NFE)
AF:
0.971
AC:
1079981
AN:
1111904
Other (OTH)
AF:
0.974
AC:
58708
AN:
60252
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
2217
4434
6650
8867
11084
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21642
43284
64926
86568
108210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.980
AC:
149130
AN:
152234
Hom.:
73054
Cov.:
30
AF XY:
0.980
AC XY:
72928
AN XY:
74434
show subpopulations
African (AFR)
AF:
0.994
AC:
41298
AN:
41528
American (AMR)
AF:
0.978
AC:
14955
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.951
AC:
3301
AN:
3472
East Asian (EAS)
AF:
1.00
AC:
5168
AN:
5168
South Asian (SAS)
AF:
0.990
AC:
4778
AN:
4824
European-Finnish (FIN)
AF:
0.975
AC:
10345
AN:
10606
Middle Eastern (MID)
AF:
0.969
AC:
285
AN:
294
European-Non Finnish (NFE)
AF:
0.971
AC:
66057
AN:
68026
Other (OTH)
AF:
0.970
AC:
2049
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
157
314
470
627
784
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
914
1828
2742
3656
4570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.970
Hom.:
43927
Bravo
AF:
0.980
Asia WGS
AF:
0.996
AC:
3462
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Jun 19, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
1.1
DANN
Benign
0.56
PhyloP100
-1.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3025052; hg19: chr6-43748643; API